Comparison
Company
Score
Quality
Valuation
Financial
Technical
Why is IGM Biosciences, Inc. ?
1
With a growth in Net Sales of 11353.19%, the company declared Outstanding results in Jun 25
- OPERATING CASH FLOW(Y) Highest at USD -156.51 MM
- NET SALES(HY) Higher at USD 144.12 MM
- ROCE(HY) Highest at -47.82%
How much should you buy?
- Overall Portfolio exposure to IGM Biosciences, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is IGM Biosciences, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
IGM Biosciences, Inc.
-86.3%
-0.75
111.78%
S&P 500
20.78%
0.96
19.87%
Quality key factors
Factor
Value
Sales Growth (5y)
170.96%
EBIT Growth (5y)
16.61%
EBIT to Interest (avg)
-189.33
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-145.10
Sales to Capital Employed (avg)
0.19
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
86.88%
ROCE (avg)
0
ROE (avg)
0
Valuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
79.35
EV to EBIT
0.38
EV to EBITDA
0.41
EV to Capital Employed
0.46
EV to Sales
-24.52
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
118.81%
ROE (Latest)
-16082.30%
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Sideways
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
Mildly Bearish
Technical Movement
Not enough Data to analyse Financial Trend
Not enough Data to analyse Financial Trend
Here's what is working for IGM Biosciences, Inc.
Net Sales
At USD 144.12 MM has Grown at 8,130.84%
Year on Year (YoY)MOJO Watch
Sales trend is very positive
Net Sales (USD MM)
Pre-Tax Profit
At USD 131.61 MM has Grown at 374.75%
Year on Year (YoY)MOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
At USD 131.61 MM has Grown at 374.75%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Operating Cash Flow
Highest at USD -156.51 MM and Grown
In each year in the last three yearsMOJO Watch
The company has generated higher cash revenues from business operations
Operating Cash Flows (USD MM)
Operating Profit
Highest at USD 130.73 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (USD MM)
Pre-Tax Profit
Highest at USD 131.61 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is very positive
Pre-Tax Profit (USD MM)
Net Profit
Highest at USD 131.61 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Net Profit trend is very positive
Net Profit (USD MM)
Net Sales
Higher at USD 144.12 MM
than preceding 12 month period ended Jun 2025MOJO Watch
In the half year the company has already crossed sales of the previous twelve months
Net Sales (USD MM)
EPS
Highest at USD 1.58
in the last five periodsMOJO Watch
Increasing profitability; company has created higher earnings for shareholders
EPS (USD)
Debtors Turnover Ratio
Highest at 580.2%
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -219.62% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for IGM Biosciences, Inc.
Cash and Eqv
Lowest at USD 256.42 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Debt-Equity Ratio
Highest at -103.34 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Non Operating Income
Highest at USD 0.01 MM
in the last five periodsMOJO Watch
Increased income from non business activities may not be sustainable
Non Operating income






